Efficacy and Safety of Filgotinib as Induction and Maintenance Therapy for Crohn's Disease: Results From the Phase 3 Randomized, Double-Blind, Placebo-Controlled DIVERSITY1 Study

被引：0
|
作者：
Vermeire, Severine [1 ]
Rubin, David T. [2 ]
Watanabe, Mamoru [3 ]
Schreiber, Stefan [4 ]
Mehta, Rajiv [5 ]
Roblin, Xavier [6 ]
Genovese, Mark C. [7 ]
Masior, Tomasz [8 ]
Barron, Rahul [8 ]
Le Brun, Franck-Olivier [8 ]
Danese, Silvio [9 ]
机构：
[1] Univ Ziekenhuis Leuven, Leuven, Vlaams Brabant, Belgium
[2] Univ Chicago Med, Ctr Inflammatory Bowel Dis, Chicago, IL USA
[3] Tokyo Med & Dent Univ, Adv Res Inst, Tokyo, Japan
[4] Univ Hosp Schleswig Holstein, Kiel, Schleswig Holst, Germany
[5] Digest Sci Hosp, Surat Inst, Surat, Gujarat, India
[6] Univ Hosp St Etienne, St Etienne, Pays De La Loir, France
[7] Gilead Sci Inc, Foster City, CA USA
[8] Galapagos GmbH, Basel, Basel Stadt, Switzerland
[9] Univ Vita Salute San Raffaele, IRCCS San Raffaele Sci Inst, Milan, Lombardia, Italy
来源：
AMERICAN JOURNAL OF GASTROENTEROLOGY | 2023年 / 118卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
S904
引用
下载
收藏
页码：S673 / S675
页数：3
相关论文
共 50 条
  • [21] Safety and efficacy of ataluren in nmDMD patients from Study 041, a phase 3, randomized, double-blind, placebo-controlled trial
    McDonald, C.
    Wu, S.
    Gulati, S.
    Komaki, H.
    Ruiz-Garcia, M.
    Kostera-Pruszczyk, A.
    Vlodavets, D.
    Chae, J.
    Jong, Y.
    Karachunski, P.
    Statland, J.
    Lorentzos, M.
    Penematsa, V
    Chou, C.
    Lin, M.
    Werner, C.
    Trifillis, P.
    Gordon, G.
    Klein, M.
    NEUROMUSCULAR DISORDERS, 2022, 32
  • [22] A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 827 in Subjects With Moderate to Severe Crohn's Disease
    Targan, Stephan R.
    Feagan, Brian G.
    Vermeire, Severine
    Panaccione, Remo
    Melmed, Gil Y.
    Blosch, Consuelo
    Newmark, Richard
    Zhang, Nan
    Chon, Yun
    Lin, Shao-Lee
    Klekotka, Paul
    GASTROENTEROLOGY, 2012, 143 (03) : E26 - E26
  • [23] Safety and Efficacy of Ataluren in nmDMD Patients from Study 041, a Phase 3, Randomized, Double-Blind, Placebo-Controlled Trial
    McDonald, Craig M.
    Wu, Shiwen
    Gulati, Sheffali
    Komaki, Hirofumi
    Escobar, Rosa E.
    Kostera-Pruszczyk, Anna
    Vlodavets, Dmitry
    Chae, Jong-Hee
    Jong, Yuh-Jyh
    Karachunski, Peter
    Statland, Jeffrey
    Lorentzos, Michelle
    Penematsa, Vinay
    Chou, Connie
    Lin, Min
    Werner, Christian
    Trifillis, Panayiota
    Gordon, Gregory
    Koladicz, Karyn
    Mastrandrea, Nicholas
    Klein, Matthew
    NEUROLOGY, 2023, 100 (17)
  • [24] GLANCE Results of a phase 2, randomized, double-blind, placebo-controlled study
    Goodman, A. D.
    Rossman, H.
    Bar-Or, A.
    Miller, A.
    Miller, D. H.
    Schmierer, K.
    Lublin, F.
    Khan, O.
    Bormann, N. M.
    Yang, M.
    Panzara, M. A.
    Sandrock, A. W.
    NEUROLOGY, 2009, 72 (09) : 806 - 812
  • [25] CETACAINE EFFICACY - A DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED STUDY
    LACHTER, J
    JACOBS, R
    LAVY, A
    SUISSA, A
    WEISLER, A
    EIDELMAN, S
    GASTROENTEROLOGY, 1988, 94 (05) : A245 - A245
  • [26] The safety and efficacy of Omalizumab in chronic idiopathic/dpontaneous urticaria: Results from a phase iii randomized, double-blind, placebo-controlled study
    Katelaris, C. H.
    Maurer, M.
    Staubach, P.
    Ashby, M.
    Canvin, J.
    Ledford, D.
    Kaplan, A.
    Jakob, T.
    Rosen, K.
    AUSTRALASIAN JOURNAL OF DERMATOLOGY, 2014, 55 : 37 - 37
  • [27] Efficacy and Safety of IncobotulinumtoxinA in the Treatment of Upper Facial Lines: Results From a Randomized, Double-Blind, Placebo-Controlled, Phase III Study
    Kerscher, Martina
    Rzany, Berthold
    Prager, Welf
    Turnbull, Catriona
    Trevidic, Patrick
    Inglefield, Christopher
    DERMATOLOGIC SURGERY, 2015, 41 (10) : 1149 - 1157
  • [28] Efficacy and safety of anamorelin HCl in NSCLC patients: Results from a randomized, double-blind, placebo-controlled, multicenter phase II study
    Temel, J.
    Bondarde, S.
    Jain, M.
    Allen, S.
    Mann, W.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S269 - S270
  • [29] Safety and efficacy results from a randomized, double-blind, placebo-controlled study of alglucosidase alfa for the treatment of Pompe disease in juveniles and adults
    Laforet, P.
    Clemens, P. R.
    Corzo, D.
    Escolar, D.
    Florence, J.
    van der Ploeg, A.
    Lake, S.
    Mayhew, J.
    Pestronk, A.
    Rosenbloom, B.
    Skrinar, A.
    Wasserstein, M.
    NEUROMUSCULAR DISORDERS, 2008, 18 (9-10) : 832 - 833
  • [30] Efficacy and Safety of Novel Aspirin Formulations: A Randomized, Double-Blind, Placebo-Controlled Study
    Mollace, Rocco
    Gliozzi, Micaela
    Macri, Roberta
    Tavernese, Annamaria
    Musolino, Vincenzo
    Carresi, Cristina
    Maiuolo, Jessica
    Muscoli, Carolina
    Tomino, Carlo
    Rosano, Giuseppe Maria
    Fini, Massimo
    Volterrani, Maurizio
    Silvestrini, Bruno
    Mollace, Vincenzo
    PHARMACEUTICS, 2022, 14 (01)
12345